VP
Vijay Paul Karwal
About Vijay Paul Karwal
Data last updated:
Vijay Paul Karwal is a Director at Onesource Specialty Pharma Limited (since 2025). The company operates in Chemicals. Onesource Specialty Pharma Limited reported revenue of ₹1,437 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Onesource Specialty Pharma Limited L74140MH2007PLC432497 | Director | 27 Feb 2025 | 2007 | ₹1,437 Cr (FY 2026) | Active |
Board colleagues of Vijay Paul Karwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Allada Trisha | Onesource Specialty Pharma Limited | Company Secretary | |
| Anurag Bhagania | Onesource Specialty Pharma Limited | Cfo | |
| Arun Kumar Pillai | 00084845 | Onesource Specialty Pharma Limited | Director |
| Bharat Dhirajlal Shah | 00136969 | Onesource Specialty Pharma Limited | Director |
| Claudio Dr Albrecht | 10109819 | Onesource Specialty Pharma Limited | Director |
| Colin Bond Michael | 10982819 | Onesource Specialty Pharma Limited | Director |
| Debarati Sen | 07521172 | Onesource Specialty Pharma Limited | Director |
| Neeraj Sharma | 09402652 | Onesource Specialty Pharma Limited | Managing Director |
| Rashmi Harshadrai Barbhaiya | 10593871 | Onesource Specialty Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Paul Karwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Paul Karwal
Vijay Paul Karwal currently holds 1 directorship: Onesource Specialty Pharma Limited (Director, since 27 Feb 2025, revenue ₹1,437 Cr (FY 2026)).
Vijay Paul Karwal was first appointed on 27 Feb 2025 as Director at Onesource Specialty Pharma Limited.
The current boards of Vijay Paul Karwal's companies include Allada Trisha (Onesource Specialty Pharma Limited), Anurag Bhagania (Onesource Specialty Pharma Limited), Arun Kumar Pillai (Onesource Specialty Pharma Limited), Bharat Dhirajlal Shah (Onesource Specialty Pharma Limited), Claudio Dr Albrecht (Onesource Specialty Pharma Limited), Colin Bond Michael (Onesource Specialty Pharma Limited), among others.